Deliberately damaging DNA could boost the effectiveness of immunotherapy in kidney cancer 20 Sep 2022 DNA damage is one of the foundational causes of cancer. But researchers have now found that deliberately causing DNA damage – by delivering additional treatments like radiotherapy – could improve the effectiveness of immunotherapy for some people with kidney cancer. Find out more Show/Hide
Ovarian cancer drug offers new genetically targeted approach against range of cancers 23 Apr 2021 A type of drug used against ovarian and breast cancers could offer a brand new targeted approach for treating a range of cancers with particular genetic defects, including a common form of kidney cancer. Find out more Show/Hide